> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Advisory Panel to Review Diabetes Drug
- URL: https://www.fdaweb.com/fda-advisory-panel-to-review-diabetes-drug/
- Published: 2017-10-03T12:00:00.000Z
- Updated: 2026-09-14T22:53:45.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139774

*Federal Register* notice: FDA has announced a 10/18 Endocrinologic and Metabolic Drugs Advisory Committee meeting. Panel members are scheduled to discuss the safety and efficacy of a Novo Nordisk NDA for semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-03/pdf/2017-21176.pdf?ref=fdaweb.com).